SUBSEQUENT EVENTS (Details) - USD ($)	3 Months Ended	6 Months Ended	12 Months Ended
	Mar. 16, 2025	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Mar. 12, 2025
Subsequent Event [Line Items]
Stock issuance proceeds			$ 3,626,000	$ 23,954,000	$ 8,236,000
Exercise of warrants			$ 0	$ 712,000	$ 2,000
ATM Shares
Subsequent Event [Line Items]
Number of shares issued (in shares)		0		12,560,150
Stock issuance proceeds				$ 24,900,000
2023 Sales Agreement
Subsequent Event [Line Items]
Number of shares issued (in shares)			2,216,692
Stock issuance proceeds			$ 3,800,000
Private Placement
Subsequent Event [Line Items]
Number of shares issued (in shares)				301,810	1,000
Exercise of warrants				$ 700,000	$ 2,360
Exercise of warrants (in shares)				237,012
Number of warrants issued (in shares)		845,000		845,000
Subsequent Event | 2023 Sales Agreement
Subsequent Event [Line Items]
Number of shares issued (in shares)	1,223,935
Stock issuance proceeds	$ 2,500,000
Shares remain for sale	0
Subsequent Event | Private Placement
Subsequent Event [Line Items]
Number of shares issued (in shares)	908,000
Exercise of warrants	$ 2,100,000
Warrants and rights outstanding						0
Subsequent Event | Pfizer Agreement
Subsequent Event [Line Items]
Total proceeds from sale of products	4,000,000
Subsequent Event | Brazil Agreement with Fiocruz
Subsequent Event [Line Items]
Total proceeds from sale of products	$ 2,900,000